Intravenous Thrombolysis for Acute Ischemic Stroke in a Patient Receiving Rivaroxaban
Rivaroxaban is an oral direct factor Xa inhibitor increasingly used in stroke prevention in nonvascular atrial fibrillation, primary prevention and treatment of venous thromboembolism, and secondary prevention in acute coronary syndromes.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Anne Landais, Caroline Ginoux Tags: Case Report Source Type: research